Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis in cancer and cancer immunotherapy. | Cancer Commun (Lond) | 2022 | 35133083 | PubTator, text mining | PubMed |
| Focus on the Mechanisms and Functions of Pyroptosis, Inflammasomes, and Inflammatory Caspases in Infectious Diseases. | Oxid Med Cell Longev | 2022 | 35132346 | PubTator, text mining | PubMed |
| The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli. | Sci Rep | 2022 | 35132157 | PubTator, text mining | PubMed |
| Exotoxin S secreted by internalized Pseudomonas aeruginosa delays lytic host cell death. | PLoS Pathog | 2022 | 35130333 | PubTator, text mining | PubMed |
| Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review. | Heliyon | 2022 | 35128104 | PubTator, text mining | PubMed |
| A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. | Acta Pharm Sin B | 2022 | 35127393 | PubTator, text mining | PubMed |
| The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. | Mol Med | 2022 | 35123387 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis. | Cell Death Dis | 2022 | 35115505 | PubTator, text mining | PubMed |
| Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation. | Inflamm Res | 2022 | 35113170 | PubTator, text mining | PubMed |
| A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma. | Aging (Albany NY) | 2022 | 35085103 | PubTator, text mining | PubMed |
| Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis. | J Cell Mol Med | 2022 | 35083859 | PubTator, text mining | PubMed |
| CD63 and C3AR1: The Potential Molecular Targets in the Progression of Septic Shock. | Int J Gen Med | 2022 | 35082520 | PubTator, text mining | PubMed |
| Inflammatory Caspases: Toward a Unified Model for Caspase Activation by Inflammasomes. | Annu Rev Immunol | 2022 | 35080918 | PubTator, text mining | PubMed |
| Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer. | J Inflamm Res | 2022 | 35079221 | PubTator, text mining | PubMed |
| Human NAIP/NLRC4 and NLRP3 inflammasomes detect Salmonella type III secretion system activities to restrict intracellular bacterial replication. | PLoS Pathog | 2022 | 35073381 | PubTator, text mining | PubMed |
| Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases. | Mol Neurobiol | 2022 | 35066762 | PubTator, text mining | PubMed |
| Novel Risk Classification Based on Pyroptosis-Related Genes Defines Immune Microenvironment and Pharmaceutical Landscape for Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 35053610 | PubTator, text mining | PubMed |
| Nephropathic Cystinosis: Pathogenic Roles of Inflammation and Potential for New Therapies. | Cells | 2022 | 35053306 | PubTator, text mining | PubMed |
| P. aeruginosa biofilm activates the NLRP3 inflammasomes in vitro. | Microb Pathog | 2022 | 35038547 | PubTator, text mining | PubMed |
| Inhibition of circular RNA circ_0138959 alleviates pyroptosis of human gingival fibroblasts via the microRNA-527/caspase-5 axis. | Bioengineered | 2022 | 35030963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=53